C5ORF35 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.810400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.497600E-01
Normal-vs-Stage2
5.909000E-01
Normal-vs-Stage3
8.454400E-01
Normal-vs-Stage4
4.025600E-01
Stage1-vs-Stage2
7.397400E-01
Stage1-vs-Stage3
5.729400E-01
Stage1-vs-Stage4
3.076200E-01
Stage2-vs-Stage3
3.135800E-01
Stage2-vs-Stage4
2.431400E-01
Stage3-vs-Stage4
1.235410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.009000E-01
Normal-vs-AfricanAmerican
8.062600E-01
Normal-vs-Asian
6.370600E-01
Caucasian-vs-AfricanAmerican
1.495580E-01
Caucasian-vs-Asian
1.327820E-02
AfricanAmerican-vs-Asian
7.132400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.937000E-01
Normal-vs-Female
4.677600E-01
Male-vs-Female
2.416800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.128400E-01
Normal-vs-Age(41-60Yrs)
5.280600E-01
Normal-vs-Age(61-80Yrs)
6.289800E-01
Normal-vs-Age(81-100Yrs)
6.513000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.556400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.341400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.938200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.933400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.586000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.291000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.312200E-01
Normal-vs-Daily Drinker
8.008800E-01
Normal-vs-Weekly Drinker
6.480000E-01
Normal-vs-Occasional Drinker
5.711000E-01
Normal-vs-Social Drinker
6.950400E-01
Non Drinker-vs-Daily Drinker
4.919200E-01
Non Drinker-vs-Weekly Drinker
4.533800E-01
Non Drinker-vs-Occasional Drinker
3.524800E-01
Non Drinker-vs-Social Drinker
2.336600E-01
Daily Drinker-vs-Weekly Drinker
6.716200E-01
Daily Drinker-vs-Occasional Drinker
6.926000E-01
Daily Drinker-vs-Social Drinker
4.777200E-01
Weekly Drinker-vs-Occasional Drinker
8.441000E-01
Weekly Drinker-vs-Social Drinker
9.527000E-01
Occasional Drinker-vs-Social Drinker
8.392600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.313040E-01
Normal-vs-Grade 2
6.790200E-02
Normal-vs-Grade 3
1.951820E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.883600E-02
Grade 1-vs-Grade 3
1.256070E-02
Grade 1-vs-Grade 4
1.313040E-01
Grade 2-vs-Grade 3
4.589400E-01
Grade 2-vs-Grade 4
6.790200E-02
Grade 3-vs-Grade 4
1.951820E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.415200E-01
Normal-vs-NonDiabetic
6.616400E-01
Diabetic-vs-NonDiabetic
3.158000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.192800E-01
Normal-vs-NoPancreatitis
5.901200E-01
Pancreatitis-vs-NoPancreatitis
8.511200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.439800E-01
Normal-vs-N1
5.465400E-01
N0-vs-N1
8.570800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.180000E-01
Normal-vs-TP53-NonMutant
3.707200E-01
TP53-Mutant-vs-TP53-NonMutant
5.361200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
